MedPath

The effect of augmentation of Gabapentin and Memantine with Selective Serotonin Re uptake Inhibitors (SSRIs) in treatment of patients with Obsessive Compulsive Disorder (OCD).

Not Applicable
Conditions
Obsessive Compulsive Disorder.
Obsessive Compulsive Disorder
Registration Number
IRCT2016062623705N6
Lead Sponsor
Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences , Kermanshah Univers
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
75
Inclusion Criteria

Diagnosis of obsessive-compulsive disorder according to the DSM-5 by psychologist; patients that their first reference for treatment or at least one month from cutting drug treatment is passed; Age range 20-40 years.
Exclusion criteria: History of organic disease Seizures, diabetes, liver or kidney failure, hypothyroidism; Concomitant use of cardiac medications, Blood pressure, hormones, thyroid; Having other major psychiatric disease and substance abuse; Medical allergy to SSRI, Memantine with Gabapentin; Unwillingness participate in the study; Require hospitalization or receive ECT.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Obsessive-compulsive disorder. Timepoint: The beginning of the study (baseline), week four and end of the study (week eight). Method of measurement: Based on the severity of obsessive-compulsive disorder.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath